FDA Panel To Review PMA Application For HeartWare Ventricular Assist Device NASDAQ The company noted that its PMA submission encompasses data from its pivotal ADVANCE clinical trial, an FDA approved Investigational Device Exemption study designed to evaluate the HVAD System as a bridge to heart transplantation for patients with ... HeartWare Announces Date for FDA Advisory Committee Panel |
